McKesson (MCK:NYS) Fundamental Valuation Report

Fundamental Valuation Report

McKesson(MCK:NYS)

Healthcare:Medical Distribution

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$122.04 (USD) 10/01/2019

Weighted Valuation
$117.84 (USD)

Overall Rating
Fairly valued to slightly Overvalued by 3.4%

Valuation Models Analyst Consensus: $129.00 (USD)
(in order of importance) Comparables: $94.32 (USD)
Multiples: $131.39 (USD)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Overvalued on a Comparable Valuation
Asset: Undervalued on an Asset Valuation

Company Overview (MCK:NYS USD)

Price 122.04
Range 117.45 – 122.59
52 week 108.23 – 176.72
Open 118.08
Vol / Avg. 2.16M/2.05M
Mkt cap 23.84B
P/E 187.92
Div/yield 1.30/0.01
EPS 0.32
Shares 195.38M
Beta 1.06

Company Description

McKesson is a major distributor of pharmaceuticals and medical products in the United States. The firm plays a critical role along the pharmaceutical supply chain as it is able to procure and distribute drugs more efficiently than its pharmacy clients and pharma manufacturing suppliers.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for MCK:NYS

Using a discounted cash flow model we generated an intrinsic value of $333.33 (USD) for MCK:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

MCK:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $333.33 1% 5% 1% 5%
WACC (or Ke) 7.57 $428.29 $270.19
Terminal Growth Rate 2.60 $276.25 $419.16
Tax Rate 0.22 $354.11 $312.54
Cash Flow 4,663,990,800 $316.10 $350.55
Capital Expenditures -389,400,000 $331.98 $334.68
Long Term Debt 8,107,000,000 $335.40 $331.25

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $94.32 (USD) for MCK:NYS. We also generated a valuation of $124.18 (USD) using other metrics and comparables.
The comparable companies were AmerisourceBergen (ABC:NYS), Cardinal Health (CAH:NYS) and Henry Schein (HSIC:NAS).

Company MCK:NYS End Date Value
Earnings/Share $0.65 (USD)
Book Value/Share $47.73 (USD)
Sales/Share $1,033.96 (USD)
Cash Flow/Share $16.29 (USD)
EBITDA/Share $7.22 (USD)
Price Based on Comps Adjustment Factor (%)
$12.51 (USD) -19.4
$185.36 (USD) 12.6
$386.22 (USD) -69.8
$168.00 (USD) -48.3
$72.05 (USD) -12.6
MCK:NYS Ratios Used Average Values ABC:NYS CAH:NYS HSIC:NAS
175.35 PE Ratio 19.25 9.88 18.66 29.19
2.31 PB Ratio 3.88 5.38 2.25 4.03
0.11 PS Ratio 0.37 0.10 0.10 0.92
6.78 PCF Ratio 12.68 11.61 7.13 19.30
19.94 EV to EBITDA 9.98 9.37 7.09 13.47

Multiples

Using a multiples approach we generated a valuation of  $131.39 (USD) for MCK:NYS

Company MCK:NYS End Date Value
Earnings/Share $0.65 (USD)
Book Value/Share $47.73 (USD)
Sales/Share $1,033.96 (USD)
Cash Flow/Share $16.29 (USD)
EBITDA/Share $7.22 (USD)
Price Based on Comps Adjustment Factor
$12.07 (USD) 0
$193.87 (USD) 0
$195.98 (USD) 0
$176.32 (USD) 0
$78.73 (USD) 0
Ratios Ratio Average
PE Ratio 18.57
PB Ratio 4.06
PS Ratio 0.19
PCF Ratio 10.82
EV to EBITDA 10.90

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  MCK:NYS for the last 10 years was  3.85

We ran the Adjusted Book Value for  MCK:NYS and generated a book value of  $46.17 (USD)
By multiplying these we get an adjusted valuation of  $177.97 (USD)

Analyst Data

In the Stockcalc database there are 2 analysts that provide a valuation for MCK:NYS. The 2 analysts have a concensus valuation for MCK:NYS for 2020 of $129.00 (USD).

MCK:NYS McKesson

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
1 2 1 3.0000 Hold 2019-1-9

Current Price: 122.04 USD

Analyst Consensus
USD Millions 2019 2020 2021
Mean EPS 13.53 14.12 14.75
# EPS Analysts 4 3 1
Mean Revenue 214,825.40 221,526.40 228,560.60
# Revenue Analysts 2 2 1
Mean Target Price 129.00
Mean Cash Flow 15.44 13.78 23.82
Mean EBITDA 4,076.70 4,285.30 4,545.80
Mean Net Income 2,700.40 2,785.60 2,815.00
Mean Debt Outstanding 5,223.30 5,223.30 5,223.30
Mean Tax Rate
Mean Growth Rate 7.64
Mean Capital Expenditure 578.50 590.00

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


AmerisourceBergen (ABC:NYS) Fundamental Valuation Report

Fundamental Valuation Report

AmerisourceBergen(ABC:NYS)

Healthcare:Medical Distribution

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$87.43 (USD) 21/11/2018

Weighted Valuation
$96.00 (USD)

Overall Rating
Undervalued by 9.8%

Valuation Models Analyst Consensus: $96.00 (USD)
(in order of importance)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Undervalued on a Comparable Valuation
Asset: Undervalued on an Asset Valuation

Company Overview (ABC:NYS USD)

Price 87.43
Range 87.10 – 89.30
52 week 78.98 – 105.48
Open 88.52
Vol / Avg. 1.12M/1.61M
Mkt cap 18.53B
P/E 11.61
Div/yield 1.52/0.02
EPS 7.53
Shares 211.93M
Beta 0.97

Company Description

AmerisourceBergen is one of three major pharmaceutical distributors in the U.S., with highly efficient distribution assets. The firm’s activities include procurement, inventory management, reimbursement consulting, sales forecasts, and logistics services. The firm is also a wholesale leader within the high-growth specialty distribution niche.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for ABC:NYS

Using a discounted cash flow model we generated an intrinsic value of $365.85 (USD) for ABC:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

ABC:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $365.85 1% 5% 1% 5%
WACC (or Ke) 8.17 $458.58 $303.18
Terminal Growth Rate 3.00 $309.56 $449.15
Tax Rate -0.37 $377.18 $354.52
Cash Flow 2,715,400,067 $350.31 $381.39
Capital Expenditures 0 $365.85 $365.85
Long Term Debt 4,407,216,000 $366.89 $364.81

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $143.90 (USD) for ABC:NYS. We also generated a valuation of $86.29 (USD) using other metrics and comparables.
The comparable companies were Cardinal Health (CAH:NYS), Henry Schein (HSIC:NAS) and McKesson (MCK:NYS).

Company ABC:NYS End Date Value
Earnings/Share $7.53 (USD)
Book Value/Share $14.62 (USD)
Sales/Share $740.00 (USD)
Cash Flow/Share $9.61 (USD)
EBITDA/Share $8.52 (USD)
Price Based on Comps Adjustment Factor (%)
$348.03 (USD) 20.2
$46.02 (USD) 0.0
$303.15 (USD) -79.2
$93.99 (USD) -44.9
$122.50 (USD) 25.8
ABC:NYS Ratios Used Average Values CAH:NYS HSIC:NAS MCK:NYS
18.03 PE Ratio 96.82 62.47 29.97 198.03
6.02 PB Ratio 3.15 2.49 4.34 2.61
0.12 PS Ratio 0.41 0.12 0.99 0.12
9.16 PCF Ratio 11.82 5.76 22.04 7.66
13.20 EV to EBITDA 14.38 7.67 13.58 21.89

Multiples

Using a multiples approach we generated a valuation of  $135.37 (USD) for ABC:NYS

Company ABC:NYS End Date Value
Earnings/Share $7.53 (USD)
Book Value/Share $14.62 (USD)
Sales/Share $740.00 (USD)
Cash Flow/Share $9.61 (USD)
EBITDA/Share $8.52 (USD)
Price Based on Comps Adjustment Factor
$216.11 (USD) 0
$138.81 (USD) 0
$100.04 (USD) 0
$74.28 (USD) 0
$147.59 (USD) 0
Ratios Ratio Average
PE Ratio 28.70
PB Ratio 9.50
PS Ratio 0.14
PCF Ratio 7.73
EV to EBITDA 17.32

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  ABC:NYS for the last 10 years was  9.41

We ran the Adjusted Book Value for  ABC:NYS and generated a book value of  $13.76 (USD)
By multiplying these we get an adjusted valuation of  $129.50 (USD)

Analyst Data

In the Stockcalc database there are 3 analysts that provide a valuation for ABC:NYS. The 3 analysts have a concensus valuation for ABC:NYS for 2019 of $96.00 (USD).

ABC:NYS AmerisourceBergen

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
3 1 0 4.4000 Outperform 2018-11-20

Current Price: 87.43 USD

Analyst Consensus
USD Millions 2019 2020
Mean EPS 7.01 7.49
# EPS Analysts 3 2
Mean Revenue 178,314.30 188,754.80
# Revenue Analysts 2 1
Mean Target Price 96.00
Mean Cash Flow 11.61 11.78
Mean EBITDA 2,448.10 2,513.70
Mean Net Income 1,508.80 1,606.50
Mean Debt Outstanding
Mean Tax Rate
Mean Growth Rate 8.68
Mean Capital Expenditure 462.70 459.00

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


Cardinal Health (CAH:NYS) Fundamental Valuation Report

Fundamental Valuation Report

Cardinal Health(CAH:NYS)

Healthcare:Medical Distribution

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$53.65 (USD) 07/11/2018

Weighted Valuation
$59.67 (USD)

Overall Rating
Undervalued by 11.2%

Valuation Models Analyst Consensus: $59.67 (USD)
(in order of importance)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Undervalued on a Comparable Valuation
Asset: Undervalued on an Asset Valuation

Company Overview (CAH:NYS USD)

Price 53.65
Range 52.59 – 53.70
52 week 48.40 – 75.23
Open 52.80
Vol / Avg. 2.9M/3.78M
Mkt cap 16.09B
P/E 66.23
Div/yield 1.86/0.04
EPS 0.81
Shares 299.86M
Beta 0.95

Company Description

Cardinal Health is a major distributor of pharmaceuticals and medical supplies to pharmacies and hospitals. It is also a major logistical partner for many branded manufacturers, providing market forecasting, product production, inventory efficiency, and distribution services to these players. Its largest retail pharmacy customer is CVS Health retail pharmacy operations.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for CAH:NYS

Using a discounted cash flow model we generated an intrinsic value of $191.45 (USD) for CAH:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

CAH:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $191.45 1% 5% 1% 5%
WACC (or Ke) 6.16 $244.61 $156.13
Terminal Growth Rate 1.20 $159.41 $239.68
Tax Rate 0.02 $201.44 $181.53
Cash Flow 3,203,722,175 $181.33 $201.58
Capital Expenditures -170,800,000 $190.98 $191.92
Long Term Debt 5,532,000,000 $192.38 $190.53

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $70.42 (USD) for CAH:NYS. We also generated a valuation of $97.20 (USD) using other metrics and comparables.
The comparable companies were AmerisourceBergen (ABC:NYS), Henry Schein (HSIC:NAS) and McKesson (MCK:NYS).

Company CAH:NYS End Date Value
Earnings/Share $0.81 (USD)
Book Value/Share $20.21 (USD)
Sales/Share $434.31 (USD)
Cash Flow/Share $8.79 (USD)
EBITDA/Share $9.24 (USD)
Price Based on Comps Adjustment Factor (%)
$66.43 (USD) -10.2
$88.25 (USD) -0.5
$178.27 (USD) -72.3
$85.19 (USD) -50.4
$150.61 (USD) -19.0
CAH:NYS Ratios Used Average Values ABC:NYS HSIC:NAS MCK:NYS
62.47 PE Ratio 82.01 18.03 29.97 198.03
2.50 PB Ratio 4.37 6.15 4.34 2.61
0.12 PS Ratio 0.41 0.12 0.99 0.12
5.76 PCF Ratio 12.95 9.16 22.04 7.66
7.71 EV to EBITDA 16.30 13.45 13.58 21.89

Multiples

Using a multiples approach we generated a valuation of  $73.33 (USD) for CAH:NYS

Company CAH:NYS End Date Value
Earnings/Share $0.81 (USD)
Book Value/Share $20.21 (USD)
Sales/Share $434.31 (USD)
Cash Flow/Share $8.79 (USD)
EBITDA/Share $9.24 (USD)
Price Based on Comps Adjustment Factor
$16.32 (USD) 0
$76.75 (USD) 0
$92.52 (USD) 0
$89.10 (USD) 0
$91.97 (USD) 0
Ratios Ratio Average
PE Ratio 20.15
PB Ratio 3.80
PS Ratio 0.21
PCF Ratio 10.14
EV to EBITDA 9.96

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  CAH:NYS for the last 10 years was  3.73

We ran the Adjusted Book Value for  CAH:NYS and generated a book value of  $19.61 (USD)
By multiplying these we get an adjusted valuation of  $73.14 (USD)

Analyst Data

In the Stockcalc database there are 3 analysts that provide a valuation for CAH:NYS. The 3 analysts have a concensus valuation for CAH:NYS for 2019 of $59.67 (USD).

CAH:NYS Cardinal Health

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
3 2 0 4.2000 Outperform 2018-11-6

Current Price: 53.65 USD

Analyst Consensus
USD Millions 2019 2020
Mean EPS 4.89 5.38
# EPS Analysts 4 3
Mean Revenue 140,572.30 145,159.80
# Revenue Analysts 2 2
Mean Target Price 59.67
Mean Cash Flow 6.21 8.17
Mean EBITDA 2,951.40 3,018.50
Mean Net Income 1,467.10 1,625.80
Mean Debt Outstanding 4,026.00 4,026.00
Mean Tax Rate
Mean Growth Rate 59.29
Mean Capital Expenditure 538.10 577.90

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


Comcast (CMCSA:NAS) and CNOOC (CNU:TSE) Upgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.

Why Do Companies Get Upgraded?

Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
CEO CNOOC Ltd 3 0 1 0 0 0 4.5000 4.2500 Outperform
AMP Ameriprise Financial Inc 1 0 3 0 0 0 3.5000 3.2500 Hold
CAH Cardinal Health Inc 2 1 3 0 0 0 3.8333 3.5000 Outperform
ES Eversource Energy 3 0 2 1 1 0 3.4286 3.1429 Hold
CBRE CBRE Group Inc 1 1 1 0 0 0 4.0000 3.6667 Outperform
EFX Equifax Inc 8 3 3 0 0 0 4.3571 3.8000 Outperform
AEE Ameren Corp 1 0 3 0 0 0 3.5000 3.0000 Hold
PNR Pentair PLC 2 0 4 0 0 0 3.6667 3.3333 Outperform
DVA DaVita Inc 1 0 3 0 0 0 3.5000 3.0000 Hold
ECA Encana Corp 13 5 1 1 0 0 4.5000 4.3000 Outperform
SHI Sinopec Shanghai Petrochemical Co Ltd 1 0 0 0 1 0 3.0000 1.0000 Hold
AN AutoNation Inc 1 1 2 0 1 0 3.2000 3.0000 Hold
SNX Synnex Corp 1 0 0 0 0 0 5.0000 3.0000 Buy
DAN Dana Inc 2 0 2 0 0 0 4.0000 3.6667 Outperform
CVNA Carvana Co 1 0 1 0 0 0 4.0000 3.0000 Outperform
UFS Domtar Corp 1 1 6 0 1 0 3.1111 3.0000 Hold
BBU Brookfield Business Partners LP 0 1 1 0 0 0 3.5000 3.0000 Hold
NEP NextEra Energy Partners LP 5 0 1 0 0 0 4.6667 4.6000 Buy
RH RH 3 0 3 0 0 0 4.0000 3.6667 Outperform
HBM Hudbay Minerals Inc 6 6 3 0 0 0 4.2000 4.0667 Outperform
ARA American Renal Associates Holdings Inc 0 0 1 0 0 0 3.0000 0.0000 Hold
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
CNU CNOOC Ltd 3 0 1 0 0 0 4.5000 4.2500 Outperform
ECA Encana Corp 13 5 1 1 0 0 4.5000 4.3000 Outperform
BPY.UN Brookfield Property Partners LP 1 2 2 0 0 0 3.8000 3.0000 Outperform
UFS Domtar Corp 1 1 6 0 1 0 3.1111 3.0000 Hold
CEE Centamin PLC 3 2 0 0 0 0 4.6000 4.5000 Buy
BBU.UN Brookfield Business Partners LP 0 1 1 0 0 0 3.5000 3.0000 Hold
HBM Hudbay Minerals Inc 6 6 3 0 0 0 4.2000 4.0667 Outperform
GTE Gran Tierra Energy Inc 4 4 3 1 0 0 3.9167 2.0000 Outperform
WEF Western Forest Products Inc 3 2 0 0 0 0 4.6000 4.4000 Buy
RSI Rogers Sugar Inc 1 2 2 0 0 0 3.8000 3.5000 Outperform
APY Anglo Pacific Group PLC 4 1 0 0 0 0 4.8000 4.6667 Buy
SBB Sabina Gold & Silver Corp 2 6 2 0 0 0 4.0000 3.8889 Outperform
AKG Asanko Gold Inc 0 2 5 0 1 0 3.0000 2.7500 Hold
HZM Horizonte Minerals PLC 0 1 0 0 0 1 2.0000 0.0000 Underperform
TSX Venture Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
RHT Reliq Health Technologies Inc 0 1 0 0 0 0 4.0000 0.0000 Outperform
SIM Siyata Mobile Inc 1 0 0 0 0 0 5.0000 4.5000 Buy
American Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
GTE Gran Tierra Energy Inc 4 4 3 1 0 0 3.9167 2.0000 Outperform
AKG Asanko Gold Inc 0 2 5 0 1 0 3.0000 2.7500 Hold
UFAB Unique Fabricating Inc 1 0 0 0 0 0 5.0000 4.5000 Buy
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
CMCSA Comcast Corp 6 1 0 0 0 0 4.8571 4.7143 Buy
DISH DISH Network Corp 3 1 2 0 0 0 4.1667 4.0000 Outperform
NKTR Nektar Therapeutics Inc 2 0 1 0 0 0 4.3333 4.0000 Outperform
BPY Brookfield Property Partners LP 1 2 2 0 0 0 3.8000 3.0000 Outperform
ACOR Acorda Therapeutics Inc 1 0 2 0 0 0 3.6667 3.0000 Outperform
BTAI BioXcel Therapeutics Inc 1 0 0 0 0 0 5.0000 0.0000 Buy

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

CMCSA:NAS Comcast

https://corporate.comcast.com
Comcast has 164000 employees and is headquartered in United States.
Comcast Corp is a media and technology company. It mainly involves in the cable industry and owns Comcast Cable, E!, NBCUniversal, and the NBC broadcast network.

CNU:TSE CNOOC

http://www.cnoocltd.com
CNOOC has 19718 employees and is headquartered in Hong Kong.
CNOOC Ltd is an oil and gas company. It is engaged in the exploration, development, production and sale of crude oil, natural gas and other petroleum products.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

British American Tobacco (BTI:NYS) and America Movil (AMOV:NYS) Downgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been downgraded by at least one analyst in the last few days.

Why Do Companies Get Downgraded?

Companies can get downgraded for a number of reasons but primarily due to reduced future earnings potential due to loss of contracts, faultering product lines, increasing costs relative to revenue or financial risk.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
BTI British American Tobacco PLC 4 0 2 0 0 0 4.3333 4.6000 Outperform
AMOV America Movil SAB de CV 0 0 2 0 1 0 2.3333 3.6667 Underperform
AMX America Movil SAB de CV 0 0 2 0 1 0 2.3333 3.6667 Underperform
CAH Cardinal Health Inc 0 1 4 0 0 0 3.2000 3.5000 Hold
OGS ONE Gas Inc 0 0 1 0 1 0 2.0000 2.3333 Underperform
BIG Big Lots Inc 1 0 2 0 0 0 3.6667 4.3333 Outperform
WDR Waddell & Reed Financial Inc 0 0 1 0 2 0 1.6667 2.5000 Underperform
OIBR.C Oi SA 0 0 0 0 1 0 1.0000 2.0000 Sell
HZN Horizon Global Corp 1 0 1 0 0 0 4.0000 4.3333 Outperform
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
LUN Lundin Mining Corp 4 5 4 0 0 0 4.0000 4.4615 Outperform
PJC.A The Jean Coutu Group (PJC) Inc 0 0 0 0 2 0 1.0000 1.6667 Sell
ENF Enbridge Income Fund Holdings Inc 2 0 6 0 0 0 3.5000 3.5556 Hold
DSG The Descartes Systems Group Inc 6 2 4 0 0 0 4.1667 4.2500 Outperform
MAG MAG Silver Corp 5 4 0 0 0 0 4.5556 4.6000 Buy
SGY Surge Energy Inc 5 3 4 0 0 0 4.0833 4.0909 Outperform
KBL K-Bro Linen Inc 2 0 3 0 0 0 3.8000 4.0000 Outperform
BAR Balmoral Resources Ltd 1 1 0 0 0 0 4.5000 5.0000 Outperform
TSX Venture Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
MJN Cronos Group Inc 2 1 1 0 0 0 4.2500 4.5000 Outperform
SIM Siyata Mobile Inc 1 1 0 0 0 0 4.5000 5.0000 Outperform
American Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
MAG MAG Silver Corp 5 4 0 0 0 0 4.5556 4.6000 Buy
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
NKTR Nektar Therapeutics Inc 2 0 1 0 0 0 4.3333 4.5000 Outperform
MAT Mattel Inc 0 1 2 0 0 0 3.3333 3.7500 Hold
DSGX The Descartes Systems Group Inc 6 2 4 0 0 0 4.1667 4.2500 Outperform
STBZ State Bank Financial Corp 1 0 1 0 0 0 4.0000 5.0000 Outperform
ZYNE Zynerba Pharmaceuticals Inc 2 0 3 0 0 0 3.8000 4.0000 Outperform
FLKS Flex Pharma Inc 1 0 1 0 0 0 4.0000 4.3333 Outperform
JNP Juniper Pharmaceuticals Inc 0 0 1 0 0 0 3.0000 4.0000 Hold

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

BTI:NYS British American Tobacco

http://www.bat.com
British American Tobacco has 49817 employees and is headquartered in United Kingdom.
British American Tobacco PLC manufactures and sells cigarettes and other tobacco products under the brands Dunhill, Kent, Lucky Strike, Pall Mall and Rothmans. It also offers Vapour Products, like e-cigarettes, and Tobacco Heating Products.

AMOV:NYS America Movil

http://www.americamovil.com
America Movil has 194193 employees and is headquartered in Mexico.
America Movil SAB de CV is a telecom company. It provides telecommunications services in various countries which include wireless service, fixed-line, broadband and Pay TV services.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

JPMorgan Chase (JPM:NYS) and BHP Billiton (BBL:NYS) Downgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been downgraded by at least one analyst in the last few days.

Why Do Companies Get Downgraded?

Companies can get downgraded for a number of reasons but primarily due to reduced future earnings potential due to loss of contracts, faultering product lines, increasing costs relative to revenue or financial risk.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
JPM JPMorgan Chase & Co 5 0 4 0 1 0 3.8000 4.0000 Outperform
BBL BHP Billiton PLC 2 0 2 1 1 0 3.1667 3.2000 Hold
RIO Rio Tinto PLC 4 0 2 1 0 0 4.0000 4.1667 Outperform
PNC PNC Financial Services Group Inc 3 0 6 0 0 0 3.6667 3.8889 Outperform
CAH Cardinal Health Inc 2 1 3 0 0 0 3.8333 4.0000 Outperform
PRGO Perrigo Co PLC 4 0 2 0 1 0 3.8571 4.0000 Outperform
RMD ResMed Inc 0 0 4 0 0 0 3.0000 3.2500 Hold
DATA Tableau Software Inc 4 0 4 1 0 0 3.7778 3.9000 Outperform
WFT Weatherford International PLC 4 0 4 0 0 0 4.0000 4.1111 Outperform
YELP Yelp Inc 5 0 4 0 1 0 3.8000 3.8889 Outperform
SHAK Shake Shack Inc 1 0 1 0 0 0 4.0000 5.0000 Outperform
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
VII Seven Generations Energy Ltd 6 4 0 0 0 0 4.6000 4.6364 Buy
GC Great Canadian Gaming Corp 1 1 3 0 0 0 3.6000 4.0000 Outperform
CNE Canacol Energy Ltd 4 1 2 0 0 0 4.2857 4.5714 Outperform
WRG Western Energy Services Corp 1 1 4 0 0 0 3.5000 3.7143 Hold
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
INFO IHS Markit Ltd 1 0 3 1 0 0 3.2000 3.4000 Hold
DISCK Discovery Communications Inc 2 1 5 0 1 0 3.3333 3.3750 Hold
DISCB Discovery Communications Inc 2 1 5 0 1 0 3.3333 3.3750 Hold
DISCA Discovery Communications Inc 2 1 5 0 1 0 3.3333 3.3750 Hold
CAKE Cheesecake Factory Inc 0 0 4 0 0 0 3.0000 3.5000 Hold
ICPT Intercept Pharmaceuticals Inc 3 0 1 0 1 0 3.8000 4.3333 Outperform
AKBA Akebia Therapeutics Inc 1 0 1 0 0 0 4.0000 4.3333 Outperform
AXON Axovant Sciences Ltd 2 0 1 0 0 0 4.3333 5.0000 Outperform
HABT The Habit Restaurants Inc 0 0 1 0 0 0 3.0000 5.0000 Hold

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

JPM:NYS JPMorgan Chase

http://www.jpmorganchase.com
JPMorgan Chase has 249257 employees and is headquartered in United States.
JPMorgan Chase & Co is a financial services firm and a banking institution. It is engaged in investment banking, commercial banking, treasury and securities services, asset management, retail financial services, and credit card businesses.

BBL:NYS BHP Billiton

http://www.bhpbilliton.com
BHP Billiton has 65000 employees and is headquartered in United Kingdom.
BHP Billiton PLC is a producer of major commodities. The company’s operations involved exploration, development and production of oil and gas, mining of copper, iron ore, and metallurgical coal and thermal (energy) coal.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

Cardinal Health (CAH:NYS) and Boston Properties (BXP:NYS) Upgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.

Why Do Companies Get Upgraded?

Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
CAH Cardinal Health Inc 2 1 2 0 0 0 4.0000 3.8000 Outperform
BXP Boston Properties Inc 3 1 3 0 0 0 4.0000 3.8571 Outperform
KOF Coca-Cola Femsa SAB de CV 0 0 1 0 0 0 3.0000 2.0000 Hold
KMX CarMax Inc 5 0 2 0 0 0 4.4286 4.3333 Outperform
RJF Raymond James Financial Inc 0 0 1 0 0 0 3.0000 2.0000 Hold
SPR Spirit AeroSystems Holdings Inc 4 0 1 1 1 0 3.7143 3.5714 Outperform
KRC Kilroy Realty Corp 1 0 4 0 0 0 3.4000 3.3333 Hold
DATA Tableau Software Inc 5 0 4 1 0 0 3.9000 3.8889 Outperform
AN AutoNation Inc 2 1 3 0 1 0 3.4286 3.2857 Hold
LC LendingClub Corp 1 0 2 0 2 0 2.6000 2.2000 Hold
FIT Fitbit Inc 3 0 3 0 0 0 4.0000 3.8000 Outperform
HCLP Hi-Crush Partners LP 2 1 0 0 0 0 4.6667 4.5000 Buy
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
FTT Finning International Inc 4 2 2 0 0 0 4.2500 4.0000 Outperform
CGX Cineplex Inc 4 3 2 0 0 0 4.2222 4.1111 Outperform
SSRM SSR Mining Inc 4 1 3 0 0 0 4.1250 3.8750 Outperform
AIF Altus Group Ltd 4 2 1 0 0 0 4.4286 4.0000 Outperform
LIF Labrador Iron Ore Royalty Corp 1 1 2 0 0 0 3.7500 2.7500 Outperform
TDG Trinidad Drilling Ltd 5 4 3 0 0 0 4.1667 4.0000 Outperform
VNP 5N Plus Inc 1 2 0 0 0 0 4.3333 3.6667 Outperform
CMH Carmanah Technologies Corp 1 1 0 0 0 0 4.5000 4.0000 Outperform
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
BMRN Biomarin Pharmaceutical Inc 2 1 3 0 0 0 3.8333 3.6667 Outperform
QRVO Qorvo Inc 3 0 3 0 0 0 4.0000 3.8333 Outperform
FTNT Fortinet Inc 4 0 5 0 0 0 3.8889 3.7778 Outperform
BBBY Bed Bath & Beyond Inc 1 0 5 0 0 0 3.3333 3.2857 Hold
FIVE Five Below Inc 1 0 2 0 0 0 3.6667 3.0000 Outperform
ONCE Spark Therapeutics Inc 3 0 0 0 1 0 4.0000 3.6667 Outperform
HTLD Heartland Express Inc 0 0 4 0 0 0 3.0000 2.7500 Hold
SSRM SSR Mining Inc 4 1 3 0 0 0 4.1250 3.8750 Outperform

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

CAH:NYS Cardinal Health

http://www.cardinal.com
Cardinal Health has 26500 employees and is headquartered in United States.
Cardinal Health Inc is a healthcare services company. It provides services and products for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices.

BXP:NYS Boston Properties

http://www.bostonproperties.com
Boston Properties has 785 employees and is headquartered in United States.
Boston Properties Inc is a fully integrated, self-administered and self-managed real estate investment trust. The company owns, develops and manages office properties in the United States.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.